SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA)
CUSIP: P8696W104
Q1 2017 13F Holders as of 31 Mar 2017
- Type / Class
- Equity / Common Shares, par value US$0.001 per share
- Shares outstanding
- 71,872,133
- Total 13F shares
- 18,903,143
- Share change
- -2,837,107
- Total reported value
- $108,310,000
- Price per share
- $5.73
- Number of holders
- 35
- Value change
- -$16,467,400
- Number of buys
- 13
- Number of sells
- 20
Quarterly Holders Quick Answers
What is CUSIP P8696W104?
CUSIP P8696W104 identifies SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP P8696W104:
Top shareholders of SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SAIF Advisors Ltd |
13F
|
Company |
15%
|
10,780,820
|
$63,607,000 | — | 31 Dec 2016 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
7.7%
|
5,521,262
|
$32,575,000 | — | 31 Dec 2016 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
3.7%
|
2,667,500
|
$15,738,000 | — | 31 Dec 2016 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.1%
|
1,524,800
|
$8,996,000 | — | 31 Dec 2016 | |
| UNITED SERVICES AUTOMOBILE ASSOCIATION |
13F
|
Company |
0.48%
|
346,215
|
$2,043,000 | — | 31 Dec 2016 | |
| Freedom Investment Management, Inc. |
13F
|
Company |
0.24%
|
174,966
|
$1,032,000 | — | 31 Dec 2016 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.16%
|
116,122
|
$685,000 | — | 31 Dec 2016 | |
| Invesco Ltd. |
13F
|
Company |
0.14%
|
99,509
|
$587,000 | — | 31 Dec 2016 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.12%
|
84,410
|
$498,000 | — | 31 Dec 2016 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.09%
|
64,700
|
$382,000 | — | 31 Dec 2016 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.06%
|
42,337
|
$250,000 | — | 31 Dec 2016 | |
| STATE STREET CORP |
13F
|
Company |
0.06%
|
42,325
|
$250,000 | — | 31 Dec 2016 | |
| Spark Investment Management LLC |
13F
|
Company |
0.05%
|
33,600
|
$198,000 | — | 31 Dec 2016 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.05%
|
32,900
|
$194,000 | — | 31 Dec 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
27,170
|
$160,000 | — | 31 Dec 2016 | |
| TFS CAPITAL LLC |
13F
|
Company |
0.04%
|
26,662
|
$157,000 | — | 31 Dec 2016 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.03%
|
24,938
|
$147,000 | — | 31 Dec 2016 | |
| GLG Partners LP |
13F
|
Company |
0.03%
|
24,739
|
$146,000 | — | 31 Dec 2016 | |
| GUGGENHEIM CAPITAL LLC |
13F
|
Company |
0.03%
|
21,426
|
$126,000 | — | 31 Dec 2016 | |
| Acrospire Investment Management LLC |
13F
|
Company |
0.03%
|
19,119
|
$113,000 | — | 31 Dec 2016 | |
| Genovese Burford & Brothers Wealth & Retirement Plan Management, LLC |
13F
|
Company |
0.01%
|
9,950
|
$59,000 | — | 31 Dec 2016 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.01%
|
4,293
|
$25,000 | — | 31 Dec 2016 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.01%
|
4,003
|
$23,000 | — | 31 Dec 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
3,150
|
$19,000 | — | 31 Dec 2016 | |
| Cutler Group LLC / CA |
13F
|
Company |
0%
|
2,800
|
$16,000 | — | 31 Dec 2016 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,786
|
$11,000 | — | 31 Dec 2016 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
1,611
|
$10,000 | — | 31 Dec 2016 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,607
|
$10,000 | — | 31 Dec 2016 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
1,416
|
$8,000 | — | 31 Dec 2016 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,250
|
$7,000 | — | 31 Dec 2016 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
1,000
|
$6,000 | — | 31 Dec 2016 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
500
|
$3,000 | — | 31 Dec 2016 | |
| Creative Planning |
13F
|
Company |
0%
|
500
|
$3,000 | — | 31 Dec 2016 | |
| CWM, LLC |
13F
|
Company |
0%
|
500
|
$3,000 | — | 31 Dec 2016 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
338
|
$2,000 | — | 31 Dec 2016 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0%
|
300
|
$2,000 | — | 31 Dec 2016 | |
| VALLEY WEALTH MANAGERS, INC. |
13F
|
Company |
0%
|
100
|
$1,000 | — | 31 Dec 2016 |
Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) as of Q1 2017
As of 31 Mar 2017,
SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,903,143 shares.
The largest 10 holders included
SAIF Advisors Ltd, MORGAN STANLEY, ORBIMED ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, TWO SIGMA INVESTMENTS, LP, Eqis Capital Management, Inc., GLG Partners LP, Invesco Ltd., CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, and MILLENNIUM MANAGEMENT LLC.
This page lists
35
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2017 vs Q4 2016 Across Filers
Q4 2016 holders
36
Q1 2017 holders
35
Holder diff
-1
| Investor | Q4 2016 Shares | Q1 2017 Shares | Share Diff | Share Chg % | Q4 2016 Value $ | Q1 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.